Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Short-term Investments: 2021-2022

  • Biodesix's Short-term Investments was N/A to $100,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $100,000, marking a year-over-year change of. This contributed to the annual value of $100,000 for FY2021, which is N/A change from last year.
  • As of Q2 2022, Biodesix's Short-term Investments stood at $100,000, which was down 0.00% from $100,000 recorded in Q4 2021.
  • Over the past 5 years, Biodesix's Short-term Investments peaked at $100,000 during Q4 2021, and registered a low of $100,000 during Q4 2021.
  • Its 2-year average for Short-term Investments is $100,000, with a median of $100,000 in 2022.